MHRA register of in-house tests needed, says UK diagnostics industry
This article was originally published in Clinica
Executive Summary
While the benefits of certain UK in-house tests – diagnostic tools designed and developed within a hospital’s or trust’s pathology laboratory – have led to significant benefits for patients, their exemption from EU CE marking is a concern that needs to be addressed.